Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the class of biphenyl derivatives and phosphonic acids. It features a sulfonamide linkage and a phosphonate group attached to a biphenylyl core with a methoxy substituent. The compound is listed as experimental and has not been approved for clinical use. Its mechanism of action is not explicitly described in public databases, but structurally related compounds are often investigated as inhibitors of matrix metalloproteinases (MMPs), particularly MMP2, MMP3, and MMP8[6]. No specific developer or manufacturer information is available in public sources[3][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on (1S)-1-{[(4'-methoxy-1,1'-biphenyl-4-yl)sulfonyl]amino}-2-methylpropylphosphonic acid.